Clinical Trials in Salt Lake City

Showing 16501-16520 of 16,694 trials

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

NCT00039858

The purpose of this study is to evaluate the safe and effective dose of Argatroban for prophylaxis and/or treatment of thrombosis in pediatric patients with current or previous diagnosis of heparin-induced thrombocytopenia (HIT) and thrombosis syndrome (HITTS), or who in the opinion of the investigator require alternative anticoagulation due to an underlying condition.

ThrombocytopeniaThrombosis

Encysive Pharmaceuticals24 participantsStarted Sep 2003

Los Angeles, California, United States • Orange, California, United States • Chicago, Illinois, United States +10 more locations

COMPLETEDPhase 4< 1 mile

ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations

NCT00231426

The ASSURE Study will evaluate shock conversion performance when programming the first shock of an implantable cardioverter-defibrillation (ICD) is based on an implant test consisting of either 1) a single induction of ventricular fibrillation (VF) and subsequent demonstration conversion success at 14 J or 2) an upper limit of vulnerability (ULV) test at 14 J.

Tachyarrhythmia

Boston Scientific CorporationStarted Jun 2003

Salt Lake City, Utah, United States

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations

Find Trials by Condition in Salt Lake City

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients

Amonafide in Combination With Cytarabine in Secondary AML

Clinical Investigation of the SelectSecure Pacing Lead

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

Glaser Obesity Study

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response